Showing results (451-460 of 1,988) with videos related to

Sort By:
Pageof 199
Prostate Cancer and Prostatic Diseases|July 4, 2025
Assessing racial differences in time to subsequent treatment following androgen deprivation therapy among Veterans with prostate cancerNadine A Friedrich, Jessica L Janes, Joshua Parrish, et al.
Prostate Cancer and Prostatic Diseases|October 11, 2025
Integrating systemic therapy and metastasis-directed therapy in oligometastatic hormone-sensitive prostate cancerXiaolei Shi, Jarey H Wang, Brian F Chapin, et al.
Prostate Cancer and Prostatic Diseases|September 25, 2025
Lymph node dissection based on 18F-PSMA PET/CT during radical prostatectomy for intermediate and high risk prostate cancer: interim results of a prospective, randomized studyZhuo Jia, Qiwei Liu, Kan Liu, et al.
Prostate Cancer and Prostatic Diseases|May 19, 2025
Perioperative outcomes of HoLEP, ThuLEP, and TURP in patients with prostate cancer: results from the GRAND studyNikolaos Pyrgidis, Gerald Bastian Schulz, Philipp Weinhold, et al.
Prostate Cancer and Prostatic Diseases|May 22, 2025
Abiraterone for "STAMPEDE-Like" cohort of high-risk prostate cancer in the PSMA-PET era: too much, too early?Vedang Murthy, Asesh Samanta, Priyamvada Maitre, et al.
Prostate Cancer and Prostatic Diseases|July 28, 2025
5G-remote radical prostatectomy under novel robotic systems: a prospective comparative cohort study with local surgeriesSunyi Ye, Ding Peng, Lixian Zhu, et al.
Prostate Cancer and Prostatic Diseases|July 30, 2025
Prostate specific membrane antigen focal ablation imaging (PSMA-FAB)Egesta Lopci, Massimo Lazzeri, Vittorio Fasulo, et al.
Prostate Cancer and Prostatic Diseases|June 2, 2025
Tailored use of PSA density according to multiparametric MRI index lesion location: results of a large, multi-institutional seriesLeonardo Quarta, Armando Stabile, Francesco Pellegrino, et al.
Prostate Cancer and Prostatic Diseases|October 7, 2025
Racial and ethnic differences in valuation of life expectancy in prostate cancer treatment decision makingJohn M Masterson, Renning Zheng, Michael Luu, et al.
Prostate Cancer and Prostatic Diseases|October 8, 2025
Prognostic factors of PSMA-targeted radioligand therapy in metastatic castration-resistant prostate cancer: a systematic review and meta-analysisTakafumi Yanagisawa, Akihiro Matsukawa, Paweł Rajwa, et al.
Pageof 199